Litcius/Paper detail

68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study

Christina Bergmann, Jörg H. W. Distler, Christoph Treutlein, Koray Taşçılar, Anna-Theresa Müller, Armin Atzinger, Alexandru‐Emil Matei, Johannes Knitza, Andrea‐Hermina Györfi, Anja Lück, Clara Dees, Alina Soare, Andreas Ramming, Verena Schönau, Oliver Distler, Olaf Prante, Philipp Ritt, Theresa Götz, Markus Köhner, M. Cordes, Tobias Bäuerle, Torsten Kuwert, Georg Schett, Christian Schmidkonz

2021The Lancet Rheumatology143 citationsDOI

Topics & Concepts

Interstitial lung diseasePET-CTMedicineLungFibroblastDiseaseNuclear medicinePathologyInternal medicinePositron emission tomographyChemistryIn vitroBiochemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPeptidase Inhibition and AnalysisSystemic Sclerosis and Related Diseases
68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study | Litcius